AGIO — AGIOS PHARMACEUTICALS, INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1439222 ·
Last close
$29.89
Market Cap
$1.79B
52W High
$46.00
52W Low
$22.24
ADV30
1,211,796
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | — | — | — | — | — | — | — |
| Jun 2026 | 44,745,000 | 41,749,000 | -110,552,000 | -100,703,000 | 1,108,424,000 | 99,647,000 | 82,403,000 |
| Mar 2026 | 20,746,000 | 19,427,000 | -110,025,000 | -99,111,000 | 1,184,990,000 | 113,600,000 | 75,875,000 |
| Dec 2025 | 19,967,000 | 18,088,000 | -121,578,000 | -108,039,000 | 1,297,225,000 | 89,130,000 | 104,111,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-360,596,000
Investing CF
$367,153,000
Financing CF
$12,219,000
CapEx
$-29,656,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-6.25
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-761,519,000
Inventory
$30,152,000
Receivables
$24,216,000
ST Investments
$517,929,000
EBIT TTM
$-459,024,000
Pretax Income TTM
$-412,302,000
Interest Exp TTM
—
Analysts
8
Yahoo Snapshot (yfinance, live)
Total Revenue
$140,843,008
EBITDA
$-413,884,000
Free Cash Flow
$-264,320,880
Enterprise Value
$1,155,520,896
Total Cash
$630,009,024
Total Debt
$26,528,000
Shares Out
59,809,651
Trailing EPS
$-6.31
Book Value
$16.38
ROE
-32.9%
ROA
-21.4%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 54,028,000 | -472,132,000 | -412,781,000 | 1,297,225,000 | 104,111,000 | 1,193,114,000 | -372,977,000 |
| Dec 2024 | 36,498,000 | -425,737,000 | 673,725,000 | 1,663,199,000 | 122,243,000 | 1,540,956,000 | -389,841,000 |
| Dec 2023 | 26,823,000 | -391,487,000 | -352,088,000 | 937,118,000 | 126,099,000 | 811,019,000 | -296,062,000 |
| Dec 2022 | 14,240,000 | -389,047,000 | -231,801,000 | 1,238,718,000 | 137,904,000 | 1,100,814,000 | -309,478,000 |
TTM Snapshot
Revenues TTM
$98,338,000
NetIncome TTM
$-411,286,000
OpCashFlow TTM
—
Assets (Latest)
$1,108,424,000
Forward EPS
$-4.04
Max Pain — expiry 2026-12-18
max pain strike: $30.00 · spot: $29.68 · call oi: 30,446 · put oi: 1,658
Expected Move to 2026-12-18:
±$3.24
(10.92%) —
implied range
$26.44 –
$32.92
· ATM straddle on $30.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ZYME | Zymeworks Inc. | $1.78B | $25.84 | — |
| TRAX | First Tracks Biotherapeutics, Inc. | $1.83B | $43.57 | — |
| ETON | Eton Pharmaceuticals, Inc. | $1.84B | $63.65 | — |
| STOK | Stoke Therapeutics, Inc. | $1.73B | $26.41 | — |
| HMDCF | HUTCHMED (China) Ltd | $1.88B | $2.16 | — |
News headlines (Yahoo Finance, 1h cache)
Agios Pharmaceuticals (AGIO) Stock Looks Pricey Despite Its 39% Run
2026-11-07 09:10 · Yahoo
Agios Pharmaceuticals Inc (AGIO) (Q3 2026) Earnings Call Highlights: Revenue Surges 4x on ...
2026-11-06 23:08 · Yahoo
Agios Pharmaceuticals (AGIO) Reports Q3 Loss, Beats Revenue Estimates
2026-11-05 12:15 · Yahoo
Agios Pharmaceuticals: Q3 Earnings Snapshot
2026-11-05 11:40 · Yahoo
Agios to Highlight Strength and Differentiation of Rare Hematology Portfolio with New Clinical Data for Mitapivat in Sickle Cell Disease and AG-236 in Polycythemia Vera at ASH 2026
2026-11-04 14:01 · Yahoo
Will FDA Review Delay Change Agios Stock Narrative
2026-11-04 08:18 · Yahoo
Agios Sinks 18% as FDA Delays Sickle Cell Drug Decision to 2027 Despite Being “Launch-Ready”
2026-10-30 15:56 · Yahoo
Agios Announces New PDUFA Goal Date of February 1, 2027, for Mitapivat Sickle Cell Disease sNDA; Company Is Launch-Ready and in Labeling Discussions with FDA
2026-10-30 11:00 · Yahoo
Agios Pharmaceuticals (AGIO) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
2026-10-29 13:00 · Yahoo
Did Priority Review Just Shift Agios Pharmaceuticals' (AGIO) Investment Narrative?
2026-10-20 23:23 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.